Norgen Biotek Corp. Launches a Novel kit to Collect, Concentrate, Preserve and Isolate DNA, RNA, microRNA and proteins from Urine Specimens

September 14, 2010

Norgen Biotek Corp, a privately held Canadian biotechnology company focusing principally on advancing a powerful proprietary technology for application in sample preparation for nucleic acid (DNA, RNA and microRNA) and protein purification, today announced the expansion of its basket of urine-based sample preparation products by launching 3 new urine concentration, preservation and isolation kits.

Norgen Biotek Transitions into Diagnostics with the Launch of over 30 New Kits for Nucleic Acid-Based Diagnostics

March 18, 2010

Norgen Biotek Corp., an innovative privately held Canadian biotechnology company focusing primarily on advancing powerful tools for nucleic acids (NA) and protein purification, today announced the launch of over 30 new kits for nucleic-acid based diagnostics. Norgen makes best-in-class kits for NA and protein sample preparation, and has recognized that high quality sample preparation is the key to high quality diagnostics.

Norgen Biotek Launches 10 New Kits for the Isolation of High-Quality Circulating Nucleic Acids from Blood, Plasma and Serum

February 2, 2010

Norgen Biotek Corp., an innovative privately held Canadian biotechnology company focusing primarily on advancing powerful tools for nucleic acids (NA) and protein purification, today announced the launch of 10 new kits for the fast and simple isolation of nucleic acids from blood, plasma and serum, including circulating nucleic acids. These kits provide fast, robust, reliable and simple procedures for isolating and purifying high quality macromolecules such as DNA, RNA, circulating NA and microRNA from a wide range of sample volumes (100 µL up to 10 mL).

Norgen Biotek Corp. Expands its Urine Sample Preparation Product Offering by Launching Novel Robust Urine DNA, RNA, microRNA, Proteins, Exfoliated Cells and Microorganisms Isolation Kits

January 6, 2010

Norgen Biotek Corp, a privately held Canadian biotechnology company focusing principally on advancing a powerful proprietary technology for application in sample preparation for nucleic acid (DNA, RNA and microRNA) and protein purification, today announced the expansion of its basket of urine-based sample preparation products.

Norgen Biotek Corp. Achieves ISO 13485:2003 and ISO 9001:2008 Certification

November 3, 2009

/CNW/ - Norgen Biotek Corp., an innovative Canadian biotechnology company focusing principally on advancing powerful innovations for nucleic acid and protein purification, today announced successful certification to ISO 13485:2003 and ISO 9001:2008. ISO 13485 and ISO 9001 are world-recognized quality management system standards, with ISO 13485 specifically pertaining to the requirements for a comprehensive management system for the design and manufacture of medical devices.

Pages